Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Metronidazole Benzoate
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Swiss Commission for Technology and Innovation | University of Basel | University Hospital, Basel | SocraTec R&D GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 22, 2016
Lead Product(s) : Metronidazole Benzoate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Swiss Commission for Technology and Innovation | University of Basel | University Hospital, Basel | SocraTec R&D GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Metronidazole Benzoate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate.
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 23, 2014
Lead Product(s) : Metronidazole Benzoate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable